Association Between Serum Chemokine Ligand 20 Levels and Disease Activity and Th1/Th2/Th17-Related Cytokine Levels in Rheumatoid Arthritis

CXCR3 antagonist NBI-74330 mitigates joint inflammation in Collagen-Induced arthritis model in DBA/1J mice

(2023) Sheikh F. Ahmad et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysis

(2022) Raphael Micheroli et al.   RMD Open

Chemokines and chemokine receptors: Insights from human disease and experimental models of helminthiasis

(2022) Lucas Kraemer et al.   CYTOKINE & GROWTH FACTOR REVIEWS

An update on novel therapeutic intervention in Rheumatoid arthritis

(2022) Pritha Shah et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Rheumatoid Arthritis Synovial Fluid Neutrophils Drive Inflammation Through Production of Chemokines, Reactive Oxygen Species, and Neutrophil Extracellular Traps

(2021) Helen L. Wright et al.   Frontiers in Immunology

Chemokine Receptor 5 Antagonism Causes Reduction in Joint Inflammation in a Collagen-Induced Arthritis Mouse Model

(2021) Mushtaq A. Ansari et al.   MOLECULES

Increased plasma levels of CCL20 in peripheral blood of rheumatoid arthritis patients and its association with clinical and laboratory parameters

(2021) Mehran Pournazari et al.   CLINICAL RHEUMATOLOGY

Targeting the CCR6/CCL20 axis in entheseal and cutaneous inflammation

(2021) Zhenrui Shi et al.   Arthritis & Rheumatology

Casein Kinase II exacerbates rheumatoid arthritis via promoting Th1 and Th17 cell inflammatory responses

(2021) Hua Ye et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis

(2021) Naoki Kondo et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

CXCR3 antagonist AMG487 inhibits glucocorticoid-induced tumor necrosis factor-receptor-related protein and inflammatory mediators in CD45 expressing cells in collagen-induced arthritis mouse model

(2020) Saleh A. Bakheet et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

CXC chemokine receptor 3 antagonist AMG487 shows potent anti-arthritic effects on collagen-induced arthritis by modifying B cell inflammatory profile

(2020) Saleh A. Bakheet et al.   IMMUNOLOGY LETTERS

The immunology of rheumatoid arthritis

(2020) Cornelia M. Weyand et al.   NATURE IMMUNOLOGY

The RORγt-CCR6-CCL20 axis augments Th17 cells invasion into the synovia of rheumatoid arthritis patients

(2018) Shunta Kaneko et al.   Modern Rheumatology

Immunopathogenesis of Rheumatoid Arthritis

(2017) Gary S. Firestein et al.   IMMUNITY

IL-17A synergistically enhances TNFα-induced IL-6 and CCL20 production in 3T3-L1 adipocytes

(2016) Takanori Shinjo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts

(2015) Janak L. Pathak et al.   PLoS One

Synovial fluid and serum levels of IL-17, IL-23, and CCL-20 in rheumatoid arthritis and psoriatic arthritis: a Tunisian cross-sectional study

(2011) Dalila Mrabet et al.   RHEUMATOLOGY INTERNATIONAL

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

(2010) D. Aletaha et al.   ANNALS OF THE RHEUMATIC DISEASES

Proinflammatory Cytokines Synergistically Enhance the Production of Chemokine Ligand 20 (CCL20) from Rheumatoid Fibroblast-like Synovial Cells in vitro and Serum CCL20 Is Reduced in vivo by Biologic Disease-modifying Antirheumatic Drugs

(2009) S.-Y. KAWASHIRI et al.   JOURNAL OF RHEUMATOLOGY